Energizing the Future: Nicotinamide Riboside (NR) Market Surges as Health and Wellness Trends Grow

The global Nicotinamide Riboside (NR) market is experiencing rapid growth and gaining substantial attention from various industries. Nicotinamide Riboside, also known as NR, is a form of vitamin B3 that has been garnering significant interest due to its potential health benefits and diverse applications. This burgeoning market is poised for substantial expansion in the coming years.

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nicotinamide Riboside (NR) was estimated at US$ 21.46 million in the year 2022, is projected to reach a revised size of US$ 38.76 million by 2029, growing at a CAGR of 8.32 % during the forecast period 2023-2029.

North American market for Nicotinamide Riboside (NR) was valued at $ 9.78 million in 2022 and will reach $ 17.90 million by 2029, at a CAGR of 8.49 % during the forecast period of 2023 through 2029.

Asia-Pacific market for Nicotinamide Riboside (NR) was valued at $ 6.55 million in 2022 and will reach $ 12.26 million by 2029, at a CAGR of 9.08 % during the forecast period of 2023 through 2029.

Europe market for Nicotinamide Riboside (NR) was valued at $ 3.59 million in 2022 and will reach $ 6.26 million by 2029, at a CAGR of 7.35 % during the forecast period of 2023 through 2029.

Nicotinamide Riboside is being widely used in dietary supplements, pharmaceuticals, cosmetics, and other sectors. Its applications range from anti-aging products to treatments for various health conditions, including metabolic disorders and neurodegenerative diseases.

With an increasing focus on health and wellness, consumers are seeking natural and effective solutions to improve their overall well-being. Nicotinamide Riboside has gained popularity for its potential role in enhancing cellular health and energy metabolism.

Geographically, the Nicotinamide Riboside market is expanding rapidly, with North America, Europe, and Asia-Pacific being key regions of growth. The increasing adoption of dietary supplements and nutraceuticals in these regions is contributing to market growth.

Several prominent companies are actively participating in the Nicotinamide Riboside market, developing innovative products and formulations. These players are contributing to market competitiveness and overall growth.

The following key players are covered in the report:

ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, Tiantai Biotechnology, EnzymeWorks, Suzhou MyLand Pharm & Nutrition, Shenzhen Ejion Biotechnology, Zhejiang Jiahua, Weitai Pharmaceutical

Request or buy a full version of this report -

https://www.qyresearch.com/sample/1667465

About Us:

QYResearch is a leading global market research and consulting company established in 2007. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.